See also this year's filing and all EDGAR filings for this company.
PDF Report 0001659617_2023_Moleculin_Biotech_Inc.pdf
Logs
| warning | Expenses in unusual place in relation to revenue | input.sec.calculation_linkbase.edgar_model_mapping | {'expenses_node': 'OperatingExpenses', 'revenue_node': 'Revenues', 'net_inc_node': 'NetIncomeLoss'} |
Graph
Absolute values for 0001659617, Moleculin Biotech Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 45,596,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 275,000 |
| 3 | remainder_Assets | 11,551,000 |
| 4 | LiabilitiesCurrent | 4,819,000 |
| 5 | LiabilitiesNoncurrent | 335,000 |
| 6 | remainder_Liabilities | 77,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 26,389,441 |
| 9 | ResearchAndDevelopmentExpense | 34,065,907 |
| 10 | remainder_Expenses | -3,665,681 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 303,215 |
| 13 | remainder_ComprehensiveNetIncome | -26,874 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 57,422,000 |
| 1 | Liabilities | 5,231,000 |
| 2 | Expenses | 56,789,667 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 52,191,000 |
| 5 | NetIncome | -56,486,452 |
| 6 | ComprehensiveNetIncome | -56,499,889 |
| 7 | BaseVar | 59,886,378 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.83 |
| 9 | EconomicCapitalRatio | 2.91 |
Edgar->Model Mapping
Feature Distribution
Change over Time
